False. After conducting thorough fundamental and technical analyses, alongside a comprehensive review of investor sentiment and consultations with industry professionals, I've determined that the fair value remains between $0.175 and $0.19.
Stonks92
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-447
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.66M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $22.14K | 113.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 222141 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 27805 | 2 |
View Market Depth
| Last trade - 10.23am 16/09/2024 (20 minute delay) ? |
| EYE (ASX) Chart |